$5.36
-0.10[-1.83%]
At close: Apr 18
$5.36
0[0.00%]
After Hours: 4:00PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/01/2024 | AMRX | Amneal Pharmaceuticals | FY | 2024 | $0.53 | $0.63 | $0.60 | $2.55B | $2.65B | $2.58B | Get Alert |
11/07/2023 | AMRX | Amneal Pharmaceuticals | FY | 2023 | $0.51 | $0.58 | $0.55 | $2.37B | $2.42B | $2.37B | Get Alert |
10/23/2023 | AMRX | Amneal Pharmaceuticals | FY | 2023 | $0.51 | $0.58 | $0.55 | $2.37B | $2.42B | $2.37B | Get Alert |
10/23/2023 | AMRX | Amneal Pharmaceuticals | Q3 | 2023 | — | — | — | $610.00M | $620.00M | $585.69M | Get Alert |
08/04/2023 | AMRX | Amneal Pharmaceuticals | FY | 2023 | $0.45 | $0.55 | $0.47 | $2.30B | $2.40B | $2.32B | Get Alert |
05/05/2023 | AMRX | Amneal Pharmaceuticals | FY | 2023 | $0.40 | $0.50 | $0.50 | $2.25B | $2.35B | $2.32B | Get Alert |
04/17/2023 | AMRX | Amneal Pharmaceuticals | FY | 2023 | $0.40 | $0.50 | $0.50 | $2.25B | $2.35B | $2.31B | Get Alert |
04/17/2023 | AMRX | Amneal Pharmaceuticals | Q1 | 2023 | — | — | — | $550.00M | $560.00M | $529.47M | Get Alert |
03/02/2023 | AMRX | Amneal Pharmaceuticals | FY | 2023 | $0.40 | $0.50 | $0.77 | $2.25B | $2.35B | $2.31B | Get Alert |
01/10/2023 | AMRX | Amneal Pharmaceuticals | FY | 2022 | $0.65 | $0.70 | $0.66 | $2.15B | $2.25B | $2.18B | Get Alert |
11/04/2022 | AMRX | Amneal Pharmaceuticals | FY | 2022 | $0.65 | $0.70 | $0.68 | $2.15B | $2.25B | $2.20B | Get Alert |
08/05/2022 | AMRX | Amneal Pharmaceuticals | FY | 2022 | $0.65 | $0.70 | $0.81 | $2.15B | $2.25B | $2.17B | Get Alert |
05/04/2022 | AMRX | Amneal Pharmaceuticals | FY | 2022 | $0.80 | $0.85 | $0.84 | $2.15B | $2.25B | $2.19B | Get Alert |
03/02/2022 | AMRX | Amneal Pharmaceuticals | FY | 2022 | $0.80 | $0.85 | $0.90 | $2.15B | $2.25B | $2.17B | Get Alert |
01/11/2022 | AMRX | Amneal Pharmaceuticals | FY | 2021 | $0.78 | $0.88 | $0.88 | $2.10B | $2.10B | $2.10B | Get Alert |
11/03/2021 | AMRX | Amneal Pharmaceuticals | FY | 2021 | $0.78 | $0.88 | $0.88 | $2.10B | $2.10B | $2.14B | Get Alert |
08/09/2021 | AMRX | Amneal Pharmaceuticals | FY | 2021 | $0.70 | $0.85 | $0.82 | $2.10B | $2.20B | $2.12B | Get Alert |
05/07/2021 | AMRX | Amneal Pharmaceuticals | FY | 2021 | $0.70 | $0.85 | $0.78 | $2.10B | $2.20B | $2.14B | Get Alert |
02/26/2021 | AMRX | Amneal Pharmaceuticals | FY | 2021 | $0.70 | $0.85 | $0.71 | $2.10B | $2.20B | $2.06B | Get Alert |
The last reported Earnings numbers were from March 1, 2024 for the full year 2024 and was for an earnings per share guidance in the range of $0.53 and $0.63 versus the estimated EPS of $0.60.
Browse guidance and forecast on all stocks.